JADE LEWIS: Open Payments
NPI 1487192159 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,103 in 121 payments from 21 companies in 2025. Trend: 2023 $1,563 · 2024 $1,365 · 2025 $2,103
Food & beverage: $2,103
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 31 | $548 |
| ABBVIE INC. | 16 | $277 |
| Novartis Pharmaceuticals Corporation | 15 | $271 |
| Amgen Inc. | 18 | $209 |
| PFIZER INC. | 9 | $176 |
| AstraZeneca Pharmaceuticals LP | 6 | $156 |
| Sumitomo Pharma America, Inc. | 5 | $89 |
| Astellas Pharma US Inc | 3 | $75 |
| Dexcom, Inc. | 3 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
Products named: Ozempic, LEQVIO, QULIPTA, Rybelsus, AIRSUPRA, GEMTESA, Wegovy, OTEZLA.
Industry payments across WV — which companies pay providers there.
